InvestorsHub Logo

knuts4oe

12/23/20 4:56 PM

#2125 RE: leifsmith #2123

About your statement "Given the ways of the FDA it may be years before those suffering the effects of chronic inflammation can obtain relief again", I have come to believe that the FDA is fully informed of the significance of the MYMD-1 molecule and will likely fast track it. Only time will tell.
On another note, your mention of izof-texas (eyes of Texas), made me smile as I have been trying to remember his name. He was a big contributor to the anatabine story.